In a world where non-communicable diseases are rapidly becoming a global health crisis, Egypt's potential move to tax sugary drinks could be a game-changer. This article delves into the implications of such a policy, exploring its potential impact on public health and the economy.
The Problem: A Growing Health Crisis
Non-communicable diseases, including heart disease, stroke, diabetes, and cancer, are no longer exclusive to wealthy nations. In Africa, these diseases are rising to the top of the mortality list, and a key contributor is often overlooked: sugary drinks.
The statistics are alarming. Globally, sugary beverages were linked to millions of new cases of type 2 diabetes and cardiovascular diseases in 2020, with Africa bearing the brunt of this burden. A study across nine African countries found a strong association between rising sugary drink sales and type 2 diabetes rates, particularly in rapidly urbanizing areas.
A Potential Solution: Taxing Sugary Drinks
As health economists, we wanted to quantify the impact of a targeted tax on sugary drinks in Egypt, a country with a severe health and economic burden from non-communicable diseases. Egypt's obesity rate among adults has risen to 32% in the past two decades, and non-communicable diseases account for a staggering 84% of all deaths.
Currently, Egypt applies a general sales tax to all drinks and an excise tax on non-alcoholic beverages, but there's no specific tax targeting sugary drinks. We asked: what if Egypt implemented such a tax?
The Study: Modeling the Impact
We used a proportional multi-state life table model, a tool that tracks disease progression over time, to project the effects of a 20% tax on sugary drink prices. This tax level is recommended by the World Health Organization as the minimum needed for a significant public health impact.
Our model showed a substantial drop in non-communicable diseases and significant savings in healthcare costs. Over 25 years, the tax could prevent hundreds of thousands of cases of obesity, diabetes, heart disease, strokes, and cancer, and save the country an estimated $1.8 billion in healthcare costs. This is roughly 8% of Egypt's annual health budget, and the economic benefits could be even higher when considering indirect costs like lost wages and reduced productivity.
Who Benefits?
The effects are not uniform. Young Egyptians, who consume more sugary drinks and are more responsive to price signals, benefit the most. Women also gain slightly more in healthy life years due to higher obesity rates and greater sensitivity to added sugars. This suggests the tax could help reduce gender-based health disparities.
A Broader Trend: Africa's Rising Obesity Rates
Egypt is not an isolated case. Obesity rates in sub-Saharan Africa have soared, with men's rates rising from 9% to 23% and women's rates from 17% to 39% between 1990 and 2022. South Africa, with one of the region's highest obesity rates, is projected to face a $42 billion economic burden by 2060.
South Africa is one of several African countries that have already implemented a tax on sugary drinks, with positive results. Studies show a significant reduction in sugary drink purchases, especially among lower-income households, and a reduction in sugar content exceeding volume reductions.
Limitations and Future Research
Our model has limitations. The price sensitivity estimates are based on international data, and Egyptian consumers might respond differently. The model also can't account for consumers switching to cheaper sugary drinks. Additionally, we only considered direct healthcare costs, and including broader economic factors would likely increase the estimated benefits.
Future research should explore how tax effects differ across income groups and between urban and rural areas, especially given Africa's diverse contexts.
The Policy Question: Political Will
This study doesn't suggest that a sugary drinks tax is the sole solution to Africa's non-communicable disease crisis. It's one tool among many, and its design is crucial. The tax rate, the beverages covered, and how revenue is used all impact health and equity outcomes.
The evidence shows that governments in Africa and the Middle East have a cost-effective, evidence-backed tool to address rising obesity and non-communicable disease burdens. The question now is whether the political will exists to implement it.
